What is it?
It’s triamcinolone acetonide ophthalmic suspension. It’s a suprachoroidal injection for the treatment of macular edema associated with uveitis.
Is it FDA approved?
Not yet. The FDA just accepted the new drug application so we’ll know if it gets approved near the end of this year. (via)